FDA Extends Delay of Final Rule on Nonprescription Drug Products With Additional Conditions for Use
March 25, 2025
March 25, 2025
WASHINGTON, March 25 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration (FDA) has announced an extended delay in the implementation of a final rule concerning nonprescription drug products with an additional condition for nonprescription use (ACNU).
Originally published in the Federal Register on December 26, 2024, the rule was initially set to take effect on January 27, 2025. However, following a memorandum issued by the President on January 2 . . .
Originally published in the Federal Register on December 26, 2024, the rule was initially set to take effect on January 27, 2025. However, following a memorandum issued by the President on January 2 . . .